The role of macrophage migration inhibition factor in toxic epidermal necrolysis.
Halevy
S
S
Department of Dermatology, Soroka Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Livni
E
E
D000086:Acetazolamide / Q000009:adverse effects; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D005665:Furosemide / Q000009:adverse effects; D006801:Humans; D008263:Macrophage Migration-Inhibitory Factors / Q000502:physiology*; D008264:Macrophages / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009582:Nitrofurantoin / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000503:physiopathology*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects
D000890:Anti-Infective Agents; D000892:Anti-Infective Agents, Urinary; D004232:Diuretics; D008263:Macrophage Migration-Inhibitory Factors; D005665:Furosemide; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D009582:Nitrofurantoin; D000086:Acetazolamide